Free Trial

Immunovant (IMVT) Short Interest Ratio & Short Volume

Immunovant logo
$14.41 -0.59 (-3.93%)
Closing price 04:00 PM Eastern
Extended Trading
$14.81 +0.40 (+2.80%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunovant Short Interest Data

Immunovant (IMVT) has a short interest of 20.71 million shares, representing 30.43% of the float (the number of shares available for trading by the public). This marks a -0.58% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.7, indicating that it would take 11.7 days of the average trading volume of 1.22 million shares to cover all short positions.

Current Short Interest
20,710,000 shares
Previous Short Interest
20,830,000 shares
Change Vs. Previous Month
-0.58%
Dollar Volume Sold Short
$334.47 million
Short Interest Ratio
11.7 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
169,861,000 shares
Float Size
68,060,000 shares
Short Percent of Float
30.43%
Today's Trading Volume
1,074,370 shares
Average Trading Volume
1,223,478 shares
Today's Volume Vs. Average
88%
Short Selling Immunovant?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Immunovant and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IMVT Short Interest Over Time

IMVT Days to Cover Over Time

IMVT Percentage of Float Shorted Over Time

Immunovant Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202520,710,000 shares $334.47 million -0.6%30.4%11.7 $16.15
4/15/202520,830,000 shares $322.24 million +5.8%30.5%11.7 $15.47
3/31/202519,690,000 shares $336.50 million +24.6%28.9%11.6 $17.09
3/15/202515,800,000 shares $308.42 million +2.7%22.8%11 $19.52
2/28/202515,390,000 shares $317.03 million +4.1%22.2%13.3 $20.60
2/15/202514,790,000 shares $300.68 million +12.5%21.3%13.2 $20.33
1/31/202513,150,000 shares $285.88 million +2.5%19.2%11.7 $21.74
1/15/202512,830,000 shares $313.05 million +4.7%21.7%13.8 $24.40
12/31/202412,260,000 shares $303.68 million -2.9%19.7%14.6 $24.77
12/15/202412,630,000 shares $331.92 million -0.3%20.3%14.9 $26.28
11/30/202412,670,000 shares $357.29 million -2.7%20.4%15.2 $28.20
11/15/202413,020,000 shares $346.72 million -0.6%21.0%14.5 $26.63
10/31/202413,100,000 shares $383.31 million +1.3%21.1%15.6 $29.26
10/15/202412,930,000 shares $369.15 million +2.3%20.8%14.3 $28.55
9/30/202412,640,000 shares $360.37 million +1.4%20.4%13.1 $28.51
9/15/202412,460,000 shares $369.69 million +0.6%20.1%11.9 $29.67
8/31/202412,390,000 shares $382.85 million +1.3%20.0%11.9 $30.90
8/15/202412,230,000 shares $377.66 million +9.1%19.8%10.6 $30.88
7/31/202411,210,000 shares $325.87 million +10.1%18.1%9.8 $29.07
7/15/202410,180,000 shares $310.59 million +1.6%16.5%8.9 $30.51
6/30/202410,020,000 shares $264.53 million -1.1%16.0%8.8 $26.40
6/15/202410,130,000 shares $263.38 million +10.0%16.4%8.9 $26.00
5/31/20249,210,000 shares $233.84 million -0.9%15.0%7.8 $25.39
5/15/20249,290,000 shares $287.34 million +3.7%15.3%8.7 $30.93
4/30/20248,960,000 shares $245.86 million +5.3%14.8%7.9 $27.44
4/15/20248,510,000 shares $259.30 million -5.7%14.1%7.4 $30.47
3/31/20249,020,000 shares $291.44 million -3.5%14.9%7.3 $32.31
3/15/20249,350,000 shares $285.46 million +7.7%15.3%7.1 $30.53
2/29/20248,680,000 shares $307.01 million -3.7%14.3%6.1 $35.37
2/15/20249,010,000 shares $340.58 million +8.4%14.8%6 $37.80
1/31/20248,310,000 shares $302.57 million +3.4%13.7%5.5 $36.41
1/15/20248,040,000 shares $340.57 million +7.8%13.3%5.1 $42.36
12/31/20237,460,000 shares $314.29 million -2.1%12.3%4.8 $42.13
12/15/20237,620,000 shares $325.68 million +10.6%12.6%3.1 $42.74
11/30/20236,890,000 shares $269.61 million -2.4%11.4%3.1 $39.13
11/15/20237,060,000 shares $241.73 million +5.5%11.6%3.3 $34.24
10/31/20236,690,000 shares $221.10 million -0.3%14.3%3 $33.05
10/15/20236,710,000 shares $251.02 million -8.0%14.3%3.2 $37.41
9/30/20237,290,000 shares $279.86 million +42.1%15.5%3.5 $38.39
9/15/20235,130,000 shares $111.89 million +4.7%9.7%4.6 $21.81
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
8/31/20234,900,000 shares $111.28 million +28.6%9.3%4.3 $22.71
8/15/20233,810,000 shares $78.18 million +2.7%7.3%3.4 $20.52
7/31/20233,710,000 shares $84.70 million +3.6%7.2%3.4 $22.83
7/15/20233,580,000 shares $74.25 million -2.7%6.9%3.2 $20.74
6/30/20233,680,000 shares $69.81 million +7.6%7.1%3.5 $18.97
6/15/20233,420,000 shares $72.26 million -0.3%6.6%3.2 $21.13
5/31/20233,430,000 shares $72.06 million -20.4%6.7%3.4 $21.01
5/15/20234,310,000 shares $79.35 million -4.9%8.4%4.6 $18.41
4/30/20234,530,000 shares $73.11 million -3.6%8.8%5.2 $16.14
4/15/20234,700,000 shares $67.07 million -3.5%9.2%5.5 $14.27
3/31/20234,870,000 shares $75.53 million +21.8%9.4%5.2 $15.51
3/15/20234,000,000 shares $61.64 million +16.6%7.6%3.9 $15.41
2/28/20233,430,000 shares $59.92 million +19.9%6.6%3.2 $17.47
2/15/20232,860,000 shares $51.85 million +23.3%5.5%2.6 $18.13
1/31/20232,320,000 shares $41.23 million -4.5%4.4%2 $17.77
1/15/20232,430,000 shares $45.20 million -32.5%4.7%2.1 $18.60
12/30/20223,600,000 shares $63.90 million +27.2%7.0%3.2 $17.75
12/15/20222,830,000 shares $43.04 million +8.0%5.5%2 $15.21
11/30/20222,620,000 shares $34.35 million -9.7%5.1%2.1 $13.11
11/15/20222,900,000 shares $38.54 million +7.8%5.6%2.6 $13.29
10/31/20222,690,000 shares $30.13 million -11.2%6.2%2.5 $11.20
10/15/20223,030,000 shares $27.85 million +6.3%7.0%3.2 $9.19
9/30/20222,850,000 shares $15.90 million +7.1%6.5%3.4 $5.58
9/15/20222,660,000 shares $13.51 million +56.5%6.7%7.8 $5.08
8/31/20221,700,000 shares $8.76 million +9.0%4.3%5 $5.15
8/15/20221,560,000 shares $8.05 million -4.9%3.8%4.6 $5.16
7/31/20221,640,000 shares $6.76 million -9.9%4.0%5.2 $4.12
7/15/20221,820,000 shares $7.90 million +1.1%4.4%5.4 $4.34
6/30/20221,800,000 shares $7.02 million -13.0%4.4%4.9 $3.90
6/15/20222,070,000 shares $7.14 million -10.4%5.0%5 $3.45
5/31/20222,310,000 shares $9.79 million +0.9%5.6%4.5 $4.24
5/15/20222,290,000 shares $9.25 million -8.8%5.5%4.3 $4.04
4/30/20222,510,000 shares $11.57 million +3.3%6.1%4.3 $4.61
4/15/20222,430,000 shares $12.15 million +5.2%5.9%3.9 $5.00
3/31/20222,310,000 shares $12.73 million -17.5%5.6%3.3 $5.51
3/15/20222,800,000 shares $14.76 million -3.1%6.8%4.1 $5.27
2/28/20222,890,000 shares $16.13 million +8.2%7.1%4.2 $5.58
2/15/20222,670,000 shares $15.27 million +1.1%6.6%3.7 $5.72
1/31/20222,640,000 shares $18.45 million +2.7%6.5%3.7 $6.99
1/15/20222,570,000 shares $20.20 million +11.3%N/A0 $7.86
12/31/20212,310,000 shares $19.68 million -28.3%5.7%3.6 $8.52
12/15/20213,220,000 shares $25.34 million -5.6%8.0%5.4 $7.87
11/30/20213,410,000 shares $26.26 million +3.0%8.4%6.7 $7.70
11/15/20213,310,000 shares $27.08 million -10.8%8.2%6.1 $8.18
10/29/20213,710,000 shares $29.83 million +4.2%9.2%5.9 $8.04
10/15/20213,560,000 shares $31.04 million -1.9%8.8%3.6 $8.72
9/30/20213,630,000 shares $31.54 million -15.2%9.0%3.5 $8.69
9/15/20214,280,000 shares $36.51 million -5.5%10.6%4.1 $8.53
8/31/20214,530,000 shares $39.23 million -11.5%11.2%4.2 $8.66
8/13/20215,120,000 shares $40.35 million +9.6%18.5%3.4 $7.88
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
7/30/20214,670,000 shares $48.85 million +2.2%20.5%3.2 $10.46
7/15/20214,570,000 shares $46.11 million -19.8%11.5%4 $10.09
6/30/20215,700,000 shares $60.25 million +6.0%14.3%5.2 $10.57
6/15/20215,380,000 shares $57.89 million -2.9%13.5%4.8 $10.76
5/28/20215,540,000 shares $83.99 million -13.7%13.9%4.8 $15.16
5/14/20216,420,000 shares $93.80 million +11.7%16.2%5.9 $14.61
4/30/20215,750,000 shares $93.73 million No Change14.2%4.3 $16.30
4/15/20215,750,000 shares $91.51 million -10.9%14.2%3.7 $15.92
3/31/20216,450,000 shares $96.75 million +41.1%15.9%4.1 $15.00
3/15/20214,570,000 shares $77.64 million +20.3%11.1%2.9 $16.99
2/26/20213,800,000 shares $60.57 million +12.4%9.2%2.7 $15.94
2/12/20213,380,000 shares $79.40 million +34.7%8.2%3.3 $23.49
1/29/20212,510,000 shares $98.44 million -1.6%6.2%3.3 $39.22
1/15/20212,550,000 shares $113.50 million -7.3%6.3%6.1 $44.51
12/31/20202,750,000 shares $135.66 million +118.3%6.8%6.7 $49.33
12/15/20201,260,000 shares $61.66 million -8.7%3.1%3 $48.94
11/30/20201,380,000 shares $68.77 million -28.1%3.4%3.2 $49.83
11/15/20201,920,000 shares $97.29 million -18.3%4.8%3.7 $50.67
10/30/20202,350,000 shares $100.93 million -7.1%7.7%4.4 $42.95
10/15/20202,530,000 shares $105.70 million +6.8%6.9%5 $41.78
9/30/20202,370,000 shares $83.40 million +52.9%6.4%5 $35.19
9/15/20201,550,000 shares $59.95 million +31.4%4.5%3 $38.68
8/31/20201,180,000 shares $40.07 million +26.9%3.5%2.2 $33.96
8/14/2020929,700 shares $25.40 million -13.9%2.7%2 $27.32
7/31/20201,080,000 shares $24.42 million -8.5%3.1%2.5 $22.61
7/15/20201,180,000 shares $28.54 million -11.9%3.4%2.8 $24.19
6/30/20201,340,000 shares $32.63 million +205.7%5.8%3 $24.35
6/15/2020438,300 shares $11.23 million -57.5%2.4%1.2 $25.63
5/29/20201,030,000 shares $26.43 million -24.3%5.5%3.9 $25.66

IMVT Short Interest - Frequently Asked Questions

What is Immunovant's current short interest?

Short interest is the volume of Immunovant shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 20,710,000 shares of IMVT short. 30.43% of Immunovant's shares are currently sold short. Learn More on Immunovant's current short interest.

What is a good short interest ratio for Immunovant?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMVT shares currently have a short interest ratio of 12.0. Learn More on Immunovant's short interest ratio.

Which institutional investors are shorting Immunovant?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunovant: Jane Street Group LLC, Caption Management LLC, and HAP Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Immunovant?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 30.43% of Immunovant's floating shares are currently sold short.

Is Immunovant's short interest increasing or decreasing?

Immunovant saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 20,710,000 shares, a decline of 0.6% from the previous total of 20,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Immunovant's float size?

Immunovant currently has issued a total of 169,861,000 shares. Some of Immunovant's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunovant currently has a public float of 68,060,000 shares.

How does Immunovant's short interest compare to its competitors?

30.43% of Immunovant's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Immunovant: Ascendis Pharma A/S (6.40%), Qiagen (2.35%), Roivant Sciences Ltd. (12.03%), Revolution Medicines, Inc. (8.89%), Elanco Animal Health Incorporated (5.00%), Blueprint Medicines Co. (8.76%), BridgeBio Pharma, Inc. (11.68%), Verona Pharma plc (9.87%), TG Therapeutics, Inc. (14.56%), Grifols, S.A. (1.26%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Immunovant stock?

Short selling IMVT is an investing strategy that aims to generate trading profit from Immunovant as its price is falling. IMVT shares are trading down $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunovant?

A short squeeze for Immunovant occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMVT, which in turn drives the price of the stock up even further.

How often is Immunovant's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMVT, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:IMVT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners